AT & S Austria Technologie & Systemtechnik (ATS) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
16 Dec, 2025Executive summary
Revenue increased to €846M in H1 2025/26, up 6% year-over-year (5.8% to €846.3M), with EBITDA rising to €175M (21% margin), driven by internal performance and cost management.
Operating free cash flow turned positive at €125M, a significant improvement from -€345M, supported by efficiency and cost-saving programs.
EBIT turned positive in Q2, reaching break-even for H1, but higher depreciation from new plants led to a net loss of €63.5M.
Customer diversification advanced in both PCB and IC substrate segments, reducing dependency on a few clients and supporting growth in high-performance computing and AI.
Ramp-ups at new sites (Kulim, Hinterberg, Leoben) are ongoing, with all planned product certifications completed.
Financial highlights
H1 revenue up 6% to €846M; FX-adjusted growth at 11%.
EBITDA margin improved to 21% from 19–20.6% year-over-year.
Operating free cash flow swung to +€125M from -€345M.
CapEx reduced to €84M from €254M year-over-year.
Net debt decreased to €1.4B, with a net debt/EBITDA ratio of 2.2.
Outlook and guidance
FY 2025/26 revenue expected at ~€1.7B with an EBITDA margin of ~23%.
FY 2026/27 revenue guidance confirmed at €2.1–2.4B, EBITDA margin 24–28%.
Net CapEx forecasted at €250M, mainly for IC substrate expansion in Kulim.
Positive free cash flow and EBIT anticipated for FY 2025/26.
ROCE expected below the mid-term target of 12%, and net debt/EBITDA may temporarily exceed 3.
Latest events from AT & S Austria Technologie & Systemtechnik
- Revenue up 10% to €1.314B, EBITDA margin 23%, strong outlook despite FX and supply risks.ATS
Q3 20263 Feb 2026 - Adjusted EBITDA margin rose to 27.6% despite revenue decline and net loss.ATS
Q1 20252 Feb 2026 - Stable revenue, margin gains, and Ansan sale boost liquidity amid ongoing market pressure.ATS
Q3 20259 Jan 2026 - Revenue up 3%, EBITDA margin at 26%, with major investments and cost savings; outlook cautious.ATS
Q4 202521 Nov 2025 - Revenue up 14.2% year-over-year, but net loss widened on FX and ramp-up costs.ATS
Q1 202616 Nov 2025 - Revenue and earnings fell amid price pressure, but mid-term growth targets are reaffirmed.ATS
Q2 202513 Jun 2025